Aurobindo Pharma informs about press release

22 Sep 2016 Evaluate

Aurobindo Pharma has informed about a Press Release dated September 22, 2016, titled ‘Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, allowing the product to be launched in the Pepfar market’.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1209.90 16.85 (1.41%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.35
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 913.85
Lupin 2118.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×